Zhao Y, Wang R, Cao R, Chen L, Chen L, Teng H (2025) Galangin protects against hyperuricemia via ameliorating gutkidney axis dysfunction in mice
Postbiotics may be a safer option for people with certain health conditions or sensitivities as they do not carry the risk of introducing live bacteria that could potentially cause adverse effects, such as infections or the transfer of antibiotic resistance genes
Huang B, Li X, Li Y et al (2021) Current immunotherapies for glioblastoma multiforme
aliquots remain stable for 36 months [4]
To date, the FDA has approved over 400 distinct peptides and peptide-based drugs for therapeutic use, and hundreds more are in the clinical testing pipeline
Cell (2023) 186:27832801.e20